Literature DB >> 3127118

Patient selection for intensive care: a comparison of New Zealand and United States hospitals.

J E Zimmerman1, W A Knaus, J A Judson, J H Havill, R V Trubuhovich, E A Draper, D P Wagner.   

Abstract

To examine how the use of intensive care varies, we compared 5,030 adult ICU admissions in 13 U.S. hospitals with 1,005 patients in two New Zealand (N.Z.) hospitals. Despite similar national demographic and hospital patient characteristics, there were substantial differences in the use of intensive care. The N.Z. hospitals designated 1.7% of their total beds for intensive care compared to 5.6% in the U.S. hospitals. The average age for N.Z. admissions was 42 compared to 55 in the U.S. (p less than .0001). The N.Z. ICUs admitted fewer patients with severe chronic failing health (N.Z. 8.7%, U.S. 18%) and following elective surgery (N.Z. 8%, U.S. 40%). Approximately half the N.Z. admissions were for trauma, drug overdose, and asthma while these diagnoses accounted for 11% of U.S. admissions. When controlled for differences in case mix and severity of illness, hospital mortality rates in N.Z. were comparable to the U.S. This study demonstrates substantial differences in patient selection among these U.S. and N.Z. ICUs that have equal technical and manpower capabilities and provide similar high-quality intensive care. Physicians from both countries justify the differences on medical criteria; however, both approaches to patient selection cannot be optimal. Additional outcome comparisons between acutely ill patients treated in the U.S. and N.Z. could help refine ICU selection criteria and improve the precision of clinical decision-making.

Entities:  

Keywords:  Empirical Approach; Health Care and Public Health; Professional Patient Relationship

Mesh:

Year:  1988        PMID: 3127118

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  22 in total

1.  Clinical audit in intensive care--the Meath Intensive Care Audit.

Authors:  D Mannion; C Armstrong; B O'Hare; A Feerick; G J Fitzpatrick
Journal:  Ir J Med Sci       Date:  1992-08       Impact factor: 1.568

2.  The variability of critical care bed numbers in Europe.

Authors:  A Rhodes; P Ferdinande; H Flaatten; B Guidet; P G Metnitz; R P Moreno
Journal:  Intensive Care Med       Date:  2012-07-10       Impact factor: 17.440

3.  Decision-making in intensive care--a reply to Sundström.

Authors:  K Hall
Journal:  Health Care Anal       Date:  1994-11

Review 4.  Predicting outcome in critical care: the current status of the APACHE prognostic scoring system.

Authors:  D T Wong; W A Knaus
Journal:  Can J Anaesth       Date:  1991-04       Impact factor: 5.063

Review 5.  The economics and cost-effectiveness of critical care medicine.

Authors:  D B Chalfin; I L Cohen; J Lambrinos
Journal:  Intensive Care Med       Date:  1995-11       Impact factor: 17.440

6.  International comparisons of intensive care: meeting the challenges of different worlds of intensive care.

Authors:  G Vazquez Mata; K Rowan; J E Zimmerman; E Aguayo de Hoyos; W A Knaus
Journal:  Intensive Care Med       Date:  1996-02       Impact factor: 17.440

Review 7.  Scoring and outcome audit systems relevant to emergency medicine.

Authors:  M Waters; P Nightingale
Journal:  Arch Emerg Med       Date:  1990-03

8.  Demographic characteristics of patients with severe life threatening asthma: comparison with asthma deaths.

Authors:  G N Richards; J Kolbe; J Fenwick; H H Rea
Journal:  Thorax       Date:  1993-11       Impact factor: 9.139

9.  Application of the APACHE III prognostic system in Brazilian intensive care units: a prospective multicenter study.

Authors:  P G Bastos; X Sun; D P Wagner; W A Knaus; J E Zimmerman
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

10.  Left atrial function for outcome prediction in severe sepsis and septic shock: an echocardiographic study.

Authors:  Amr S Omar; Masood ur Rahman; Said Abuhasna
Journal:  Indian J Crit Care Med       Date:  2009 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.